Overview

Real-world Clinical Efficacy of Abatacept in the T3 Data Registry

Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effectiveness of Abatacept in real-world clinical practice. The main hypothesis to be examined in this study is, "Abatacept's effectiveness results in a single real-world clinic (n = 100) are reproducible at another site (n ~= 200)".
Details
Lead Sponsor:
Arthritis Northwest PLLC
Collaborator:
Bristol-Myers Squibb
Treatments:
Abatacept